AzTrials
AzTrials

StrokePhase 3NCT00514800

Home Blood Pressure Monitoring Trial

A Phase 3 study testing Intervention - a validated home BP monitor and support from the specialist nurse in people with Stroke and Ischemic Attack, Transient, run by St George's, University of London at 3 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Design: Community based randomised trial with follow up after 12 months Participants: 360 patients admitted with stroke or TIA within the past 9 months will be recruited from the wards or outpatients and randomly allocated into two groups. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Stroke, Ischemic Attack, Transient
What is being tested?
Intervention - a validated home BP monitor and support from the specialist nurse
Could I receive a placebo?
No, everyone receives an active treatment
How many people
360 participants
Where
3 sitesUnited Kingdom
Study dates
Mar 2007to Apr 2009
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Stroke or TIA in last 9 months
  • Blood pressure above 140/85 when measured more than 1 week after stroke or on anti hypertensive medication

Who cannot join

  • Severe illness likely to dominate pattern of care
  • Already using home blood pressure monitor
  • Non-English speaking
  • Severe cognitive impairment (AMTS<7)
  • Known secondary hypertension

Trial locations and contacts

3 sites in 1 country.

United Kingdom3 sites
  • St. Helier NHS Trust

    Carshalton, Surrey, SM5 1AA

  • Mayday University Hospital

    Croydon, Surrey, CR7 7YE

  • St. George's Healthcare Trust

    London, London, SW17 0RE

Other trials in United Kingdom

About this study

Official title: Community Based Trial of Home Blood Pressure Monitoring With Nurse Led Support in Patients With Stroke or TIA Recently Discharged From Hospital

Design: Community based randomised trial with follow up after 12 months Participants: 360 patients admitted with stroke or TIA within the past 9 months will be recruited from the wards or outpatients and randomly allocated into two groups. All patients will be visited by the specialist nurse at home at baseline when she will measure their BP and administer a questionnaire. The questionnaire and BP will be repeated at 12 months follow-up by another researcher blind as to whether the patient is in intervention or control group.

Intervention: Intervention patients will be given a validated home BP monitor and support from the specialist nurse. Control patients will continue with usual care (BP monitoring by their practice).

Read more

Main outcome measures in both groups after 12months: 1.Change in systolic BP 2.Cost effectiveness: Incremental cost of the intervention to the NHS and incremental cost per quality adjusted life year gained.

Study hypothesis. Home blood pressure monitoring with nurse support wil lead to lower blood pressure after 12 months compared with usual GP care

Read the detailed description

High blood pressure in patients with stroke increases the risk of recurrence but management in the community is often inadequate. Home blood pressure monitoring may increase patients' involvement in their care, increase compliance, and reduce the need for patients to attend their GP if blood pressure is adequately controlled. However the value of home monitoring to improve BP control is unclear and there is now a window of opportunity for evaluation before their use becomes widespread in the UK. Furthermore its use in stroke patients presents unique challenges relating to the consequent neurological disability.

Being tested
Intervention - a validated home BP monitor and support from the specialist nurse, Control - usual care (BP monitoring by their practice)
Keywords
Home monitoring, Primary care, Hypertension, TIA
Medical subject headings
Stroke, Ischemic Attack, Transient, Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention - a validated home BP monitor and support from the specialist nurseBehavioural

  • Control - usual care (BP monitoring by their practice)Behavioural

    Patients will not receive a blood pressure monitor and will continue with usual GP care for hypertension management.

    GPs will be sent information about the study design, current guidelines and interpretation of home blood pressure readings.

Study groups in NCT00514800
Study groupRoleWhat they receive
InterventionExperimentalPatients will be given a home blood pressure monitor and taught how to use it and how to respond to the readings using a standardised protocol and blood pressure targets. The study nurse will follow up patients at home after a month with additional telephone support according to a defined protocol. Patients will consult their own GP for medication changes when above target. GPs will be sent information about the study design, current guidelines and interpretation of home blood pressure readings.
Receives: Behavioral: Intervention - a validated home BP monitor and support from the specialist nurse
ControlActive comparatorNot described
Receives: Behavioral: Control - usual care (BP monitoring by their practice)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reduction in systolic blood pressure taken by study team at home visit

    Measured: 12 months

Secondary outcomes (6)
  1. Reduction in diastolic blood pressure taken by study team at home visit

    Measured: 12 months

  2. Reduction in SBP and DBP taken by study team at home visit

    Measured: 6 months

  3. Number of prescribed anti hypertensive medications Number of changes to anti hypertensive medication

    Measured: 12 months

  4. EQ-5D

    Measured: 12 months

  5. FEAR

    Measured: 12 months

  6. Incremental cost of the intervention to the NHS and cost per QALY

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Aug 2007 (estimated)
  2. Study startMar 2007
  3. Study completionApr 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
360 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00514800
Sponsor's protocol ID
07.0002
Other IDs
TSA 2006/05
Status last verified
Aug 2007
First submitted
9 Aug 2007
Last updated
9 Jun 2015
Results posted
No
Data monitoring committee
No

Publications

  • Kerry SM, Markus HS, Khong TK, Cloud GC, Tulloch J, Coster D, Ibison J, Oakeshott P. Home blood pressure monitoring with nurse-led telephone support among patients with hypertension and a history of stroke: a community-based randomized controlled trial. CMAJ. 2013 Jan 8;185(1):23-31. doi: 10.1503/cmaj.120832. Epub 2012 Nov 5.

    PubMed 23128283
  • Kerry S, Markus H, Khong T, Doshi R, Conroy R, Oakeshott P. Community based trial of home blood pressure monitoring with nurse-led telephone support in patients with stroke or transient ischaemic attack recently discharged from hospital. Trials. 2008 Mar 19;9:15. doi: 10.1186/1745-6215-9-15.

    PubMed 18353175

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Intervention - a validated home BP monitor and support from the specialist nurse in people with Stroke and Ischemic Attack, Transient, run by St George's, University of London at 3 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reduction in systolic blood pressure taken by study team at home visit (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00514800, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in